How many insider declarations has ALTSCHULLER Susan filed?

ALTSCHULLER Susan has filed 3 public insider declarations with SEC (Form 4).

What is ALTSCHULLER Susan's role?

ALTSCHULLER Susan's reported role is not specified by the regulator across the filings.

Which companies does ALTSCHULLER Susan report trades for?

ALTSCHULLER Susan reports trades for 2 companies, including Cerevel Therapeutics Holdings, Inc..

What is ALTSCHULLER Susan's declared buy vs sell volume?

Across the available history, declared buys total 29k€ and disposals 0.

← Executives ★ Sign in to follow

AS

ALTSCHULLER Susan

·SEC (Form 4)

Cerevel Therapeutics Holdings, Inc.Mural Oncology plc

0

申报总数

0

公司

€29,120

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by ALTSCHULLER Susan. Officer active across 2 companies, notably Cerevel Therapeutics Holdings, Inc.. Cumulatively, 3 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €29k. History available since 14 August 2024. The latest transaction was filed on 14 August 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to ALTSCHULLER Susan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Cerevel Therapeutics Holdings, Inc. (US)Mural Oncology plc (US)

申报3 总计

▲

ALTSCHULLER Susan

Director高管2024年8月14日Mural Oncology plc

US$32,07123SEC ↗

10,000 股@ US$3.2071100.0% 占其流量Ordinary SharesSEC:0000950170-24-097576:0

标准退出：2024年11月12日 (T+90)

●

ALTSCHULLER Susan

Chief Financial Officer高管2024年8月1日Cerevel Therapeutics Holdings, Inc.

0SEC ↗

16,913 股Common StockSEC:0000950170-24-090813:0

◇

ALTSCHULLER Susan

Chief Financial Officer高管2023年12月19日Cerevel Therapeutics Holdings, Inc.

0SEC ↗

30,721 股Common StockSEC:0000950170-23-072368:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

AS

ALTSCHULLER Susan

·SEC (Form 4)

Cerevel Therapeutics Holdings, Inc.Mural Oncology plc

0

申报总数

0

公司

€29,120

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the complete record of transactions filed by ALTSCHULLER Susan. Officer active across 2 companies, notably Cerevel Therapeutics Holdings, Inc.. Cumulatively, 3 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €29k. History available since 14 August 2024. The latest transaction was filed on 14 August 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.